Literature DB >> 3518182

Radiation nephritis. Clinical manifestations and pathophysiologic mechanisms.

R J Krochak, D G Baker.   

Abstract

Radiation nephritis is both volume and dose related. Clinical experience would indicate that a minimum of one third of the renal volume needs to be excluded from nephrotoxic doses which appears to have a threshold of 2,000 cGy. The site of damage leading to renal failure appears to be the microvasculature ultimately expressed as glomerulosclerosis. How much direct damage to the tubular system contributes to this process is unclear, but undoubtedly the resultant systemic physiologic effects potentiate the expression of damage in the irradiated kidney. The acute syndrome, with all the potential manifestations of renal failure, rarely presents sooner than six months and appears to have no clear prodrome, although it would seem reasonable that a subclinical syndrome consisting of abnormalities detectable by urinalysis may occur. Treatment of radiation-induced nephritis or hypertension is no different from treatment for nephritis from any other cause and should be aggressive with lifelong follow-up. Carcinogenesis is a rare late expression of radiation-induced kidney damage.

Entities:  

Mesh:

Year:  1986        PMID: 3518182     DOI: 10.1016/0090-4295(86)90399-7

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  8 in total

1.  Association of Technetium(99m) MAG-3 renal scintigraphy with change in creatinine clearance following chemoradiation to the abdomen in patients with gastrointestinal malignancies.

Authors:  Kilian Salerno May; Gary Y Yang; Nikhil I Khushalani; Rameela Chandrasekhar; Gregory E Wilding; Leayn Flaherty; Harish K Malhotra; Richard C Russo; John C Warner; Johnny C Yap; Renuka V Iyer; Chukwumere E Nwogu; Saikrishna S Yendamuri; John F Gibbs; Hector R Nava; Dominick Lamonica; Charles R Thomas
Journal:  J Gastrointest Oncol       Date:  2010-09

2.  Semiquinone derivative isolated from Bacillus sp. INM-1 protects cellular antioxidant enzymes from γ-radiation-induced renal toxicity.

Authors:  S Mishra; D S K Reddy; V S Jamwal; D D Bansal; D D Patel; P Malhotra; A K Gupta; P K Singh; S Jawed; Raj Kumar
Journal:  Mol Cell Biochem       Date:  2013-04-01       Impact factor: 3.396

3.  Acute kidney injury in patients with systemic sclerosis participating in hematopoietic cell transplantation trials in the United States.

Authors:  Chitra Hosing; Richard Nash; Peter McSweeney; Shin Mineishi; James Seibold; Linda M Griffith; Howard Shulman; Ellen Goldmuntz; Maureen Mayes; Chirag R Parikh; Leslie Crofford; Lynette Keyes-Elstein; Daniel Furst; Virginia Steen; Keith M Sullivan
Journal:  Biol Blood Marrow Transplant       Date:  2010-08-11       Impact factor: 5.742

4.  Radiation-induced renovascular hypertension successfully treated with transluminal angioplasty: case report.

Authors:  J Milutinovic; M Darcy; K A Thompson
Journal:  Cardiovasc Intervent Radiol       Date:  1990 Feb-Mar       Impact factor: 2.740

5.  Pediatric Onco-Nephrology: Time to Spread the Word-Part II: Long-Term Kidney Outcomes in Survivors of Childhood Malignancy and Malignancy after Kidney Transplant.

Authors:  Arwa Nada; Jennifer G Jetton
Journal:  Pediatr Nephrol       Date:  2021-09-06       Impact factor: 3.651

6.  Thrombotic microangiopathy in metastatic melanoma patients treated with adoptive cell therapy and total body irradiation.

Authors:  Jennifer Tseng; Deborah E Citrin; Meryl Waldman; Donald E White; Steven A Rosenberg; James C Yang
Journal:  Cancer       Date:  2014-01-28       Impact factor: 6.860

7.  Effect of Coenzyme Q10 on Radiation Nephropathy in Rats.

Authors:  Yongkan Ki; Wontaek Kim; Yong Ho Kim; Donghyun Kim; Jin Sook Bae; Dahl Park; Hosang Jeon; Ju Hye Lee; Jayoung Lee; Jiho Nam
Journal:  J Korean Med Sci       Date:  2017-05       Impact factor: 2.153

8.  EANM dosimetry committee recommendations for dosimetry of 177Lu-labelled somatostatin-receptor- and PSMA-targeting ligands.

Authors:  Katarina Sjögreen Gleisner; Nicolas Chouin; Pablo Minguez Gabina; Francesco Cicone; Silvano Gnesin; Caroline Stokke; Mark Konijnenberg; Marta Cremonesi; Frederik A Verburg; Peter Bernhardt; Uta Eberlein; Jonathan Gear
Journal:  Eur J Nucl Med Mol Imaging       Date:  2022-03-14       Impact factor: 10.057

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.